| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.52 | 0.0007 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |